<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Open Med (Wars)</journal-id><journal-id journal-id-type="iso-abbrev">Open Med (Wars)</journal-id><journal-title-group><journal-title>Open Medicine</journal-title></journal-title-group><issn pub-type="epub">2391-5463</issn><publisher><publisher-name>De Gruyter Open</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">28352711</article-id><article-id pub-id-type="pmc">5152983</article-id><article-id pub-id-type="doi">10.1515/med-2015-0046</article-id><article-id pub-id-type="publisher-id">med-2015-0046</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group></article-categories><title-group><article-title>TVT-Exact and midurethral sling (SLING-IUFT) operative procedures: a randomized study</article-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name><surname>Aniuliene</surname><given-names>Rosita</given-names></name><email>rosita.aniuliene@kaunoklinikos.lt</email></contrib><aff id="af1-med-2015-0046">Lithuanian University of Health Sciences, Mickeviciaus str.9, Kaunas, LT-44307, Lithuania, Tel. +37068778631</aff></contrib-group><contrib-group><contrib contrib-type="author"><name><surname>Aniulis</surname><given-names>Povilas</given-names></name></contrib><aff id="af2-med-2015-0046">Clinic of Urology, Lithuanian University of Health Sciences, Lithuania</aff></contrib-group><contrib-group><contrib contrib-type="author"><name><surname>Skaudickas</surname><given-names>Darijus</given-names></name></contrib><aff id="af3-med-2015-0046">Clinic of Urology, Lithuanian University of Health Sciences, Lithuania</aff></contrib-group><pub-date pub-type="collection"><year>2015</year></pub-date><pub-date pub-type="epub"><day>10</day><month>6</month><year>2015</year></pub-date><volume>10</volume><issue>1</issue><fpage>311</fpage><lpage>317</lpage><history><date date-type="received"><day>18</day><month>3</month><year>2013</year></date><date date-type="accepted"><day>04</day><month>5</month><year>2015</year></date></history><permissions><copyright-statement>&#x000a9; 2015 Rosita Aniuliene et al</copyright-statement><copyright-year>2015</copyright-year><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-nc-nd/3.0"><license-p>This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivs 3.0 License.</license-p></license></permissions><abstract><sec><title>Objectives</title><p>The aim of the study is to compare results, effectiveness and complications of TVT exact and midurethral sling (SLING-IUFT) operations in the treatment of female stress urinary incontinence (SUI).</p></sec><sec><title>Methods</title><p>A single center nonblind, randomized study of women with SUI who were randomized to TVT-Exact and SLING-IUFT was performed by one surgeon from April 2009 to April 2011. SUI was diagnosed on coughing and Valsalva test and urodynamics (cystometry and uroflowmetry) were assessed before operation and 1 year after surgery. This was a prospective randomized study. The follow up period was 12 months. 76 patients were operated using the TVT-Exact operation and 78 patients &#x02013; using the SLING-IUFT operation. There was no statistically significant differences between groups for BMI, parity, menopausal status and prolapsed stage (no patients had cystocele greater than stage II).</p></sec><sec><title>Results</title><p>Mean operative time was significantly shorter in the SLING-IUFT group (19 &#x000b1; 5.6 min.) compared with the TVT-Exact group (27 &#x000b1; 7.1 min.). There were statistically significant differences in the effectiveness of both procedures: TVT-Exact &#x02013; at 94.5% and SLING-IUFT &#x02013; at 61.2% after one year. Hospital stay was statistically significantly shorter in the SLING-IUFT group (1. 2 &#x000b1; 0.5 days) compared with the TVT-Exact group (3.5 &#x000b1; 1.5 days). Statistically significantly fewer complications occurred in the SLING-IUFT group.</p></sec><sec><title>Conclusion</title><p>the TVT-Exact and SLING-IUFT operations are both effective for surgical treatment of female stress urinary incontinence. The SLING-IUFT involved a shorter operation time and lower complications rate., the TVT-Exact procedure had statistically significantly more complications than the SLING-IUFT operation, but a higher effectiveness.</p></sec></abstract><kwd-group><kwd>TVT- exact</kwd><kwd>SLING-IUFT</kwd><kwd>MUS</kwd><kwd>stress urinary incontinence</kwd></kwd-group></article-meta></front><body><sec><title>1 Introduction</title><p>Female stress urinary incontinence (SUI) is a common disease with a huge impact on the patient&#x02019;s quality of life [<xref rid="b1-med-2015-0046" ref-type="bibr">1</xref>, <xref rid="b2-med-2015-0046" ref-type="bibr">2</xref>].</p><p>Several reports show that urinary incontinence affects emotional, physical, as well as sexual aspects of well-being and can be a cause of anxiety and depression [<xref rid="b3-med-2015-0046" ref-type="bibr">3</xref>&#x02013;<xref rid="b7-med-2015-0046" ref-type="bibr">7</xref>].</p><p>Surgical procedures are standard for women who have failed conservative management strategies such as lifestyle changes, physical therapy, scheduled voiding regimes, and behavioral therapies [<xref rid="b5-med-2015-0046" ref-type="bibr">5</xref>].</p><p>Surgical techniques for the correction of stress incontinence have envolved during the past 100 years and have included Kelly plication, retropubic urethropexy (Marshal-Marchetti-Krantz, Burch operations), needle urethropexy, fascial and synthetic bladder neck, and, more recently, midurethral slings (MUS), which can be placed using either a retropubic or a transobturator approach [<xref rid="b9-med-2015-0046" ref-type="bibr">9</xref>]. Midurethral tension-free slings are minimally invasive procedures that have been shown to have high success rates and low overall complication rate [<xref rid="b10-med-2015-0046" ref-type="bibr">10</xref>].</p><p>The tension-free vaginal tape procedure only is the best studied and documented procedure with excellent long-term outcome data. The transobturatoric approach seemed to be equally effective according to the patient&#x02019;s subjective point of view. Promising new techniques, like the minislings, needs futher evaluation [<xref rid="b8-med-2015-0046" ref-type="bibr">8</xref>].</p><p>The Urinary Incontinence Treatment Network has published a land mark multicenter randomized controlled trial (RCT) of 597 women who underwent either a retropubic or a transobturator midurethral sling (MUS) procedure [<xref rid="b11-med-2015-0046" ref-type="bibr">11</xref>]. Retropubic and transobturator MUS demonstrated equivalent objective success rates. Vaginal mesh exposure and mesh exposure were listed as serious adverse events in 2.7 and 0.3% of women in the retropubic group, respectively. This compared with vaginal mesh exposure and mesh erosion rates of 0.3% and 0.3% in the transobturator group, respectively. These differences were not statistically significant [<xref rid="b12-med-2015-0046" ref-type="bibr">12</xref>, <xref rid="b13-med-2015-0046" ref-type="bibr">13</xref>].</p><p>A recent Cochrane review of MUS concluded that the MUS is as effective as the pubovaginal sling and retropubic colposuspension, but with fewer postoperative complications [<xref rid="b14-med-2015-0046" ref-type="bibr">14</xref>].</p><p>Although transobturator MUS was associated with less postoperative voiding dysfunction, it did result in more groin pain (12%) than retropubic MUS (1. 7%).</p><p>The updated American Urologic Association (AUA) guideline for the surgical management of female stress urinary incontinence (SUI) also concluded that synthetic MUS is appropriate treatment with similar efficacy and less morbidity than conventional nonmesh slings [<xref rid="b15-med-2015-0046" ref-type="bibr">15</xref>].</p><p>Retropubic sling systems, especially TVT, are the best studied and well documented procedures. Both have excellent long-term outcome data, with low rate of complications. Significantly higher objective cure rates were reported for TVT than TOT, but both procedures are equally effective according to the patient&#x02019;s subjective point of view. In comparison with different types of TOT, no significant differences were identified [<xref rid="b8-med-2015-0046" ref-type="bibr">8</xref>].</p></sec><sec><title>2 Materials and methods</title><p>A randomized, nonblinded, clinical study was done, with all operations performed at Kaunas clinic of Lithuanian university of health sciences by one surgeon. Informed consent was obtained preoperatively from each subject. Women were randomized by 1:1 to midurethral sling- SLING-IUFT (transobturator) and TVT-Exact (retropubic) operations. The envelopes were sealed at the same day of surgery. Patients were not blinded to the procedure postoperatively as they were made aware of differences between procedures. This study was undertaken to compare prospectively the TVT-Exact procedure concerning the effectiveness, safety and simplicity with the midurethral sling-SLING-IUFT procedure.</p><p>78 patients were subjected to TVT-Exact procedure and 76 to SLING-IUFT procedure. All those patients were available for follow-up at 12 months.</p><p>Inclusion criteria were a history of SUI with a demonstrable impact of SUI upon coughing and Valsalva tests during urodynamic (cystometry and uroflowmetry) testing [<xref rid="b16-med-2015-0046" ref-type="bibr">16</xref>].</p><p>Exclusion criteria were: previous suburethral sling, predominant overactive bladder symptoms, prolapse (cystocele) greater than stage 2, elevated postvoid residual (PVR &#x0003e;100 mL), urinary retention, progressive neurological disease, psychiatric disease and evidence of systematic infection.</p><p>The degree of the incontinence was 2&#x02013;3 according to Ingelman-Sundberg scale [<xref rid="b52-med-2015-0046" ref-type="bibr">52</xref>]. The degree of vaginal defects was evaluated using the pelvic organ prolapse quantification (POP-Q) system (17).</p><p>Cystoscopy during operation was routenly performed only in the TVT-Exact group.</p><p>Antibiotic prophylaxis was performed for all operations during surgery.</p><p>Surgical procedures (TVT-Exact and SLING-IUFT) were performed by the same surgeon, using standardized protocols.</p><sec sec-type="results"><title>2.1 Results were estimated using the following criteria</title><list list-type="simple"><list-item><p>&#x02013; Excellent &#x02013; no signs of stress incontinence, no imperative urination, no disuria.</p></list-item><list-item><p>&#x02013; Good &#x02013; no signs of stress incontinence, very mild imperative urination, no disuria.</p></list-item><list-item><p>&#x02013; Medium &#x02013; no signs of stress incontinence, imperative urination with minimal leakage, very mild disuria.</p></list-item><list-item><p>&#x02013; Bad &#x02013; stress incontinence, imperative urination, disuria, woman uses inlays.</p></list-item></list><p>Calculation was performed using SPSS-20 for Windows and statistical analysis was performed with the use of Student&#x02018;s t-test and chi-square test, Pearson&#x02018;s correlation coefficient and p&#x0003c;0.05 was considered as statistically significant.</p><p>The study was approved by the Ethic Committee of the university hospital. Permission number: BEC-MF-306.</p><sec><title>Ethical approval</title><p>The research related to human use has been complied with all the relevant national regulations, institutional policies and in accordance the tenets of the Helsinki Declaration, and has been approved by the my institutional review board.</p></sec></sec></sec><sec><title>3 Results</title><p>All patients (TVT-Exact group n=76 and SLING-IUFT group n=78) were assessed for eligibility. SUI was diagnosed for all patient, who met the inclusion criteria and signed informed consent. All patients undwent surgery were operated in the Kaunas clinic of Lithuanian University of Health Sciences, Department of Obstetrics and Gynecology (by the same surgeon). The main type of anesthesia in both groups was intravenous (80.2% and 85.8%).</p><p>There is no statistically significant differences between the two groups among patients characteristics for BMI, obesity and prolapse stage., (no patients had cystocele greater than stage II) (<xref ref-type="table" rid="t1-med-2015-0046">Table 1</xref>).</p><p>Statistically significant older patients were in the MUS group- SLING-IUFT group. Also statistically significant : there were more menopausal women in MUS (SLING-IUFT) group (<xref ref-type="table" rid="t1-med-2015-0046">Table 1</xref>).</p><p>There was no differences in the duration of stress urinary incontinence between groups (<xref ref-type="table" rid="t1-med-2015-0046">Table 1</xref>).</p><p>After 12 months, the TVT-Exact procedure is statistically significantly more effective than the SLING-IUFT (TVT-Exact&#x02013; 94.5%, SLING-IUFT &#x02013; 61.2%) (<xref ref-type="table" rid="t2-med-2015-0046">Table 2</xref>). Mean operative time was shorter in the SLING-IUFT group (19 &#x000b1; 5.7 min) compared with the TVT-Exact group (21 &#x000b1; 9.1 min.). Hospital stay was statistically significantly shorter in the SLING-IUFT group (1.5 &#x000b1; 0.5 days) than in the TVT-Exact group (3.5 &#x000b1; 1.5 days). Bladder drainage was statistically significantly rare in the SLING-IUFT group (1.3%) compare with TVT-Exact group (15.7%).</p><p>The postoperative results were very different in the groups (<xref ref-type="table" rid="t3-med-2015-0046">Table 3</xref>).</p><p>Bad results (the patient had stress urinary incontinence, imperative urination, disuria, used inlays) in TVT-Exact group included 4 (5.3%) cases and in the SLING-IUFT group, 31 (39.7%) cases. Medium results (patient didn&#x02018;t have signs of stress urinary incontinence., imperative urination was with minimal leakage and very mild disuria) in the TVT-Exact group (n=1., 1.3%), in SLING-IUFT (n=2., 2.6%), good results (patient didn&#x02018;t have signs of stress urinary incontinence., had very mild imperative urination, no disuria) in TVT-Exact group (n=11., 14.5%) in SLING-IUFT (n=10., 12.9%) and excellent results (patient didn&#x02018;t have signs of stress urinary incontinence, no imperative urination, no disuria) in the TVT-Exact group (n=60., 78.9%) in SLING-IUFT (n=35., 44.8%). The Chi-square test value- was 27.767., p &#x0003c;0.0001.</p><p>Statistically significantly fewer complications occured in the SLING-IUFT group (<xref ref-type="table" rid="t4-med-2015-0046">Table 4</xref>). Suprapubic hematoma occured only in 3.9% of the TVT-Exact group., bladder perforation occurred in 1 case in the TVT-exact group as well. Postoperative urinary retention was statistically significantly higher in the TVT-Exact group (19.7%) than in SLING-IUFT group (1.3%).</p><p>Postoperative groin pain was more significant in the SLING-IUFT group- (6.4%), compared with the TVT-Exact group &#x02013; (1.3%). There were no statistically significant differences in such complications as symptoms of irritated bladder. One instance of vaginal erosion was noticed in SLING-IUFT group.</p></sec><sec><title>4 Discussion</title><p>In the present study no statistically significant differences were noted between the two groups concerning- parity, BMI, obesity, duration of urinary incontinence, and degree of prolapse. Age was the independent risk factor for urinary incontinence [<xref rid="b51-med-2015-0046" ref-type="bibr">51</xref>].</p><p>There was a small difference in the mean operative time: it was much longer in the TVT-Exact- procedure than in the SLING-IUFT method, because in the TVT-Exact group intraoperative cystoscopy was necessary [<xref rid="b18-med-2015-0046" ref-type="bibr">18</xref>]. The duration of hospitalisation was statistically significant longer in the TVT-Exact group than in the SLING-IUFT group. These results are not in agreement with other authors [<xref rid="b19-med-2015-0046" ref-type="bibr">19</xref>], where the majority of patients were discharged from the hospital on the first postoperative day.</p><p>According to the literature, TVT provides overall subjective cure rates of more than 80% compared with less than 80% with another MUS- SPARC [<xref rid="b41-med-2015-0046" ref-type="bibr">41</xref>&#x02013;<xref rid="b44-med-2015-0046" ref-type="bibr">44</xref>]. A 2-year follow-up study demonstrated a cure rate of 97% after 12 months and 85% after 24 months concerning TOT [<xref rid="b45-med-2015-0046" ref-type="bibr">45</xref>].</p><p>The effectiveness of procedure (or cure rate) in our study was 94.5% in the TVT-Exact group and 61.2% in the SLING-IUFT group. The cure rate of the TVT-Exact procedure is in agreement with other authors with cure rates that range from 84% to 95% [<xref rid="b20-med-2015-0046" ref-type="bibr">20</xref>&#x02013;<xref rid="b23-med-2015-0046" ref-type="bibr">23</xref>,<xref rid="b38-med-2015-0046" ref-type="bibr">38</xref>]. However, the cure rate of midurethral sling- SLING-IUFT (61.2%) is worse than reported in the literature [<xref rid="b18-med-2015-0046" ref-type="bibr">18</xref>]. The older ages of women in the- SLING-IUFT group was the risk factor for the low cure rate. Severity of the incontinence, bladder hyposensitivity and cognitive deterioration among elderly women are factors that reduce the response to treatment (level 2) evidence [<xref rid="b51-med-2015-0046" ref-type="bibr">51</xref>].</p><p>Bladder perforation in our study was only- 1.3% in the TVT-Exact- group (no cases in SLING-IUFT group) and it is less than reported in the literature [<xref rid="b20-med-2015-0046" ref-type="bibr">20</xref>, <xref rid="b24-med-2015-0046" ref-type="bibr">24</xref>, <xref rid="b25-med-2015-0046" ref-type="bibr">25</xref>].</p><p>Postoperative groin pain was more statistically significant in the SLING-IUFT group, compared with TVT-Exact procedure. The data are similar to those reported in the literature [<xref rid="b40-med-2015-0046" ref-type="bibr">40</xref>]. An advantage of the MUS-TOT procedure is the low perioperative complication rate. The transobturator approach is associated with a shorter operation time, less postoperative voiding dysfunction, and fewer bladder perforations than the retropubic route. An adverse effect reported more frequently with the obturatoric approach is postoperative groin pain [<xref rid="b40-med-2015-0046" ref-type="bibr">40</xref>,<xref rid="b46-med-2015-0046" ref-type="bibr">46</xref>&#x02013;<xref rid="b50-med-2015-0046" ref-type="bibr">50</xref>]. Postoperative groin pain- in our study: in the SLING-IUFT group was higher at- 6.4%, like in the TVT-Exact group at- 1.3%.</p><p>Postoperative urinary retention was statistically significant higher in the TVT-Exact group., our data are not in agreement with the literature report [<xref rid="b26-med-2015-0046" ref-type="bibr">26</xref>]. Therefore, TVT-Exact is a safe and effective surgical treatment for female stress urinary incontinence with a good effectiveness [<xref rid="b27-med-2015-0046" ref-type="bibr">27</xref>&#x02013;<xref rid="b30-med-2015-0046" ref-type="bibr">30</xref>, <xref rid="b37-med-2015-0046" ref-type="bibr">37</xref>], but the TVT-Exact operation- is also associated with various perioperative complications [<xref rid="b31-med-2015-0046" ref-type="bibr">31</xref>&#x02013;<xref rid="b34-med-2015-0046" ref-type="bibr">34</xref>].</p><p>Several suburethral tape insertion procedures have been described, such as tension-free trans-obturator tape (TOT) either from outside to inside or inside to outside [<xref rid="b34-med-2015-0046" ref-type="bibr">34</xref>&#x02013;<xref rid="b36-med-2015-0046" ref-type="bibr">36</xref>]. One retrospective comparative study, investigating retropubic and outside- in transobturator sling, demonstrated that these procedures are equally efficacious to treat female stress urinary incontinence with a cure rate of 90% versus 84% for TOT and TVT, respectively [<xref rid="b39-med-2015-0046" ref-type="bibr">39</xref>].</p><p>The increasing number of procedures for the operative treatment of SUI leaves the surgeon not only with the freedom to choose, but also the responsibility to implant a device with which he/she feels confident and has sufficient experience [<xref rid="b8-med-2015-0046" ref-type="bibr">8</xref>].</p></sec><sec><title>5 Conclusions</title><list list-type="order"><list-item><p>The TVT-Exact operation is a very effective procedure, curing female stress urinary incontinence after 12 month of follow-up.</p></list-item><list-item><p>The SLING-IUFT operation had a low complication rate, but was less effective compared with the TVT-Exact operation.</p></list-item><list-item><p>The SLING-IUFT procedure had a shorter operation time and hospital stay than TVT-Exact procedure.</p></list-item></list></sec></body><back><ack><title>Acknowledgements</title><p>We wish to thank Lithuanian Society of Urogynecology for the general support and reasonable advises.</p></ack><fn-group><fn id="fn1-med-2015-0046"><p><bold>Authors&#x02018; Contributions</bold></p><p>RA (Rosita Aniuliene)-surgeon of all cases and general inspirator of main idea of the manuscript.</p><p>PA (Povilas Aniulis) and DS (Darijus Skaudickas)&#x02013; participated in the design and coordination of the manuscript, performed the statistic analysis, also helped to draft the manuscript and participated in patients interrogatory before and after operation.</p><p>All authors read and approved the final manuscript.</p></fn><fn id="fn2-med-2015-0046"><p><bold>Conflict of interest statement:</bold> None of the authors has a financial disclosure or conflict of interest.</p></fn></fn-group><glossary id="GL"><title>List of abbreviations</title><def-list><def-item><term id="G1">TVT-Exact</term><def><p>tension free vaginal tape exact and retropubic</p></def></def-item><def-item><term id="G2">MUS</term><def><p>midurethral sling</p></def></def-item><def-item><term id="G3">TVT-O</term><def><p>tension free vaginal obturator tape</p></def></def-item><def-item><term id="G4">SUI</term><def><p>stress urinary incontinence</p></def></def-item><def-item><term id="G5">POP-Q</term><def><p>pelvic organ prolapse quantification system</p></def></def-item><def-item><term id="G6">NS</term><def><p>non significant</p></def></def-item><def-item><term id="G7">RCT</term><def><p>randomized controlled trial</p></def></def-item><def-item><term id="G8">TOT</term><def><p>tension obturator tape.</p></def></def-item></def-list></glossary><ref-list><title>References</title><ref id="b1-med-2015-0046"><label>1</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hunskaar</surname><given-names>S</given-names></name><name><surname>Vinsnes</surname><given-names>A</given-names></name></person-group><article-title>The quality of life in women with urinary incontinence as measured by the sickness impact profile</article-title><source>J Am Geriatr Soc</source><year>1991</year><volume>39</volume><fpage>378</fpage><lpage>382</lpage><pub-id pub-id-type="pmid">2010587</pub-id></element-citation></ref><ref id="b2-med-2015-0046"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schlenk</surname><given-names>E</given-names></name><name><surname>Erlen</surname><given-names>J</given-names></name><name><surname>Jacob</surname><given-names>J</given-names></name><etal/></person-group><article-title>Health-related quality of life in chronic disorders: a comparison across studies using the MOS Sf-36</article-title><source>Qual Life Res</source><year>1998</year><volume>7</volume><fpage>57</fpage><lpage>65</lpage><pub-id pub-id-type="pmid">9481151</pub-id></element-citation></ref><ref id="b3-med-2015-0046"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Temml</surname><given-names>CGJ</given-names></name><etal/></person-group><article-title>Urinary incontinence in both sexes prevalence rates and impact on quality of life and sexual life</article-title><source>Neurourol Urodynam</source><year>2000</year><volume>19</volume><fpage>259</fpage><lpage>271</lpage></element-citation></ref><ref id="b4-med-2015-0046"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lalos</surname><given-names>O</given-names></name><name><surname>Berglund</surname><given-names>AL</given-names></name><name><surname>Lalos</surname><given-names>A</given-names></name></person-group><article-title>Impact of urinary and climacteric symptoms on social and sexual life after surgical treatment of stress urinary incontinence in women: a long term outcome</article-title><source>J Adv Nurs</source><year>2001</year><volume>33</volume><fpage>316</fpage><lpage>327</lpage><pub-id pub-id-type="pmid">11251718</pub-id></element-citation></ref><ref id="b5-med-2015-0046"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shaw</surname><given-names>C</given-names></name></person-group><article-title>A rewiev of the psychological predictors of help-seeking behavior and impact on quality of life in people with urinary incontinence</article-title><source>J Clin Nurs</source><year>2001</year><volume>10</volume><fpage>15</fpage><lpage>22</lpage><pub-id pub-id-type="pmid">11820232</pub-id></element-citation></ref><ref id="b6-med-2015-0046"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Swithinbank</surname><given-names>L</given-names></name><name><surname>Abrams</surname><given-names>P</given-names></name></person-group><article-title>The impact of urinary incontinence on the quality of life of women</article-title><source>World J Urol</source><year>1999</year><volume>17</volume><fpage>225</fpage><lpage>229</lpage><pub-id pub-id-type="pmid">10460405</pub-id></element-citation></ref><ref id="b7-med-2015-0046"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Innerkofler</surname><given-names>PC</given-names></name><name><surname>Guenther</surname><given-names>V</given-names></name><name><surname>Rehder</surname><given-names>P</given-names></name><etal/></person-group><article-title>Improvement of quality of life, anxiety and depression after surgery in patients with stress urinary incontinence: results of a longitudinal short-term follow-up</article-title><source>Health Qual Life Outcomes</source><year>2008</year><volume>6</volume><fpage>72</fpage><pub-id pub-id-type="pmid">18823552</pub-id></element-citation></ref><ref id="b8-med-2015-0046"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Heidler</surname><given-names>S</given-names></name></person-group><article-title>Female incontinence: long &#x02013;term results of slings</article-title><source>Current Opinion in Urology</source><year>2011</year><volume>21</volume><fpage>488</fpage><lpage>492</lpage><pub-id pub-id-type="pmid">21857227</pub-id></element-citation></ref><ref id="b9-med-2015-0046"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hota</surname><given-names>Lekha S</given-names></name><name><surname>Hanaway</surname><given-names>K</given-names></name><name><surname>Hacker</surname><given-names>MR</given-names></name><name><surname>Disciullo</surname><given-names>A</given-names></name><name><surname>Elkadry</surname><given-names>E</given-names></name><name><surname>Dramitinos</surname><given-names>P</given-names></name><etal/></person-group><article-title>TVT-Secur (Hammock) versus TVT-Obturator: a randomized trial of suburethral sling operative procedures</article-title><source>Female Pelvic Med Reconstr Surg</source><year>2012</year><volume>18</volume><fpage>41</fpage><lpage>45</lpage><pub-id pub-id-type="pmid">22453267</pub-id></element-citation></ref><ref id="b10-med-2015-0046"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Daneshgari</surname><given-names>F</given-names></name><name><surname>Kong</surname><given-names>W</given-names></name><name><surname>Swartz</surname><given-names>M</given-names></name></person-group><article-title>Complications of mid urethral slings: important outcomes for future clinical trials</article-title><source>J Urol</source><year>2008</year><volume>180</volume><fpage>1890</fpage><lpage>1897</lpage><pub-id pub-id-type="pmid">18801499</pub-id></element-citation></ref><ref id="b11-med-2015-0046"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Richter</surname><given-names>HE</given-names></name><name><surname>Albo</surname><given-names>ME</given-names></name><name><surname>Zyczynski</surname><given-names>HM</given-names></name><etal/></person-group><article-title>Retropubic versus transobturaror midurethral slings for stress incontinence</article-title><source>N Engl J Med</source><year>2010</year><volume>362</volume><fpage>2066</fpage><lpage>2076</lpage><pub-id pub-id-type="pmid">20479459</pub-id></element-citation></ref><ref id="b12-med-2015-0046"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brubaker</surname><given-names>L</given-names></name><name><surname>Norton</surname><given-names>PA</given-names></name><name><surname>Albo</surname><given-names>ME</given-names></name><etal/></person-group><article-title>Adverse events over two years after retropubic or transobturator midurethral sling surgery: findings from the Trial of Midurethral Slings(TOMUS) study</article-title><source>Am J Obstet Gynecol</source><year>2011</year><volume>205</volume><fpage>498e1</fpage><lpage>498e2</lpage><pub-id pub-id-type="pmid">21925636</pub-id></element-citation></ref><ref id="b13-med-2015-0046"><label>13</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chermansky</surname><given-names>Ch</given-names></name><name><surname>Winters</surname><given-names>Ch</given-names></name></person-group><article-title>Complications of vaginal mesh surgery</article-title><source>Curr Opin Urol</source><year>2012</year><volume>22</volume><fpage>287</fpage><lpage>291</lpage><pub-id pub-id-type="pmid">22617058</pub-id></element-citation></ref><ref id="b14-med-2015-0046"><label>14</label><element-citation publication-type="webpage"><article-title>FDA Public Health Notification : Serious complications associated with transvaginal placement of surgical mesh in repair of pelvic organ prolapse and stress urinary incontinence</article-title><year>2008</year><comment><ext-link ext-link-type="uri" xlink:href="http://www.fda.gov/MedicalDevices/Safety/Alertsand/Notices/PublicHealthnotifications/ucm061976.htm">http://www.fda.gov/MedicalDevices/Safety/Alertsand/Notices/PublicHealthnotifications/ucm061976.htm</ext-link></comment><date-in-citation>Accessed 1 February 2012</date-in-citation></element-citation></ref><ref id="b15-med-2015-0046"><label>15</label><element-citation publication-type="webpage"><article-title>FDA Safety Communication: UPDATE on serious complications associated with transvaginal placement of surgical mesh in repair of pelvic organ prolapse</article-title><year>2011</year><comment><ext-link ext-link-type="uri" xlink:href="http://www.fda.gov/MedicalDevices/Safety/Alertsand/Notices/PublicHealthnotifications/ucm262435.htm">http://www.fda.gov/MedicalDevices/Safety/Alertsand/Notices/PublicHealthnotifications/ucm262435.htm</ext-link></comment><date-in-citation>Accessed 1 February 2012</date-in-citation></element-citation></ref><ref id="b16-med-2015-0046"><label>16</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Auward</surname><given-names>W</given-names></name><name><surname>Freeman</surname><given-names>RM</given-names></name><name><surname>Swift</surname><given-names>S</given-names></name></person-group><article-title>Is the pelvic organ prolapse quantification system (POPQ) being used? A survey of members of the International Continence Society (ICS) and the American Urogynecologic Society (AUGS)</article-title><source>Int Urogynecol J Pelvic Floor Dysfunct</source><year>2004</year><volume>15</volume><fpage>324</fpage><lpage>327</lpage><pub-id pub-id-type="pmid">15580417</pub-id></element-citation></ref><ref id="b17-med-2015-0046"><label>17</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Abrams</surname><given-names>P</given-names></name><name><surname>Cardozo</surname><given-names>L</given-names></name><name><surname>Fall</surname><given-names>M</given-names></name><etal/></person-group><article-title>The standardisation of terminology of lower urinary tract function: report from the Standardisation Sub-Committee of the International Continence Society</article-title><source>Neurourol Urodyn</source><year>2002</year><volume>21</volume><fpage>167</fpage><lpage>178</lpage><pub-id pub-id-type="pmid">11857671</pub-id></element-citation></ref><ref id="b18-med-2015-0046"><label>18</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>de Tayrac</surname><given-names>R</given-names></name><name><surname>Xavier</surname><given-names>D</given-names></name><name><surname>Droupy</surname><given-names>S</given-names></name><name><surname>Chauveaud-Lambling</surname><given-names>A</given-names></name><name><surname>Calrvanese-Behamour</surname><given-names>L</given-names></name><name><surname>Fernandez</surname><given-names>H</given-names></name></person-group><article-title>A prospective randomized trial comparing tension-free vaginal tape and transobturator suburethral tape for surgical treatment of stress urinary incontinence</article-title><source>Am J Obstet @Gynecol</source><year>2004</year><volume>190</volume><fpage>602</fpage><lpage>608</lpage></element-citation></ref><ref id="b19-med-2015-0046"><label>19</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mellier</surname><given-names>G</given-names></name><name><surname>Benayed</surname><given-names>B</given-names></name><name><surname>Bretones</surname><given-names>S</given-names></name><name><surname>Pasquier</surname><given-names>S</given-names></name></person-group><article-title>Suburethral tape via the obturator route: Is the TOT a simplification of the TVT?</article-title><source>Int Urogynecol J Pelvic Floor Dysfunct</source><year>2004</year><volume>15</volume><fpage>227</fpage><lpage>232</lpage><pub-id pub-id-type="pmid">15517665</pub-id></element-citation></ref><ref id="b20-med-2015-0046"><label>20</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ulmsten</surname><given-names>U</given-names></name><name><surname>Falconer</surname><given-names>C</given-names></name><name><surname>Johnson</surname><given-names>P</given-names></name><name><surname>Onas</surname><given-names>M</given-names></name><name><surname>Lannaer</surname><given-names>L</given-names></name><name><surname>Nilsson</surname><given-names>CG</given-names></name><etal/></person-group><article-title>A multicenter study of tension free vaginal tape (TVT) for surgical treatment of stress urinary incontinence</article-title><source>Int Urogynecol J Pelvic Floor Dysfunct</source><year>1998</year><volume>9</volume><fpage>210</fpage><lpage>213</lpage><pub-id pub-id-type="pmid">9795826</pub-id></element-citation></ref><ref id="b21-med-2015-0046"><label>21</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Karran</surname><given-names>MM</given-names></name><name><surname>Segal</surname><given-names>JL</given-names></name><name><surname>Vassalo</surname><given-names>BJ</given-names></name><name><surname>Kleeman</surname><given-names>SD</given-names></name></person-group><article-title>Complications and untoward effects of the tension free vaginal tape procedure</article-title><source>Obstet Gynecol</source><year>2003</year><volume>101</volume><fpage>929</fpage><lpage>932</lpage><pub-id pub-id-type="pmid">12738152</pub-id></element-citation></ref><ref id="b22-med-2015-0046"><label>22</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Klutke</surname><given-names>C</given-names></name><name><surname>Siegal</surname><given-names>S</given-names></name><name><surname>Carlin</surname><given-names>B</given-names></name><name><surname>Paszkiewiez</surname><given-names>E</given-names></name><name><surname>Kirkemo</surname><given-names>A</given-names></name><name><surname>Klutke</surname><given-names>J</given-names></name></person-group><article-title>Urinary retention after tension free vaginal tape procedure incidence and treatment</article-title><source>Urology</source><year>2001</year><volume>58</volume><fpage>697</fpage><lpage>701</lpage><pub-id pub-id-type="pmid">11711343</pub-id></element-citation></ref><ref id="b23-med-2015-0046"><label>23</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ulmsten</surname><given-names>U</given-names></name><name><surname>Johnson</surname><given-names>P</given-names></name><name><surname>Rezapour</surname><given-names>M</given-names></name></person-group><article-title>A three-year follow-up of tension free vaginal tape for surgical treatment of female stress urinary incontinence</article-title><source>BJOG</source><year>1999</year><volume>106</volume><fpage>345</fpage><lpage>350</lpage></element-citation></ref><ref id="b24-med-2015-0046"><label>24</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Meschia</surname><given-names>M</given-names></name><name><surname>Pifarotti</surname><given-names>P</given-names></name><name><surname>Bernasconi</surname><given-names>F</given-names></name><etal/></person-group><article-title>Tension free vaginal tape. Analysis of outcomes and complications in 404 stress incontinent women</article-title><source>Int Urogynecol J Pelvic Floor Dysfunct</source><year>2001</year><volume>12</volume><issue>suppl 2</issue><fpage>524</fpage><lpage>527</lpage></element-citation></ref><ref id="b25-med-2015-0046"><label>25</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Moran</surname><given-names>PA</given-names></name><name><surname>Ward</surname><given-names>KL</given-names></name><name><surname>Johnson</surname><given-names>D</given-names></name><etal/></person-group><article-title>Tension free vaginal tape for primary genuine stress incontinence: a two center follow-up study</article-title><source>BUJ Int</source><year>2000</year><volume>86</volume><fpage>39</fpage><lpage>42</lpage></element-citation></ref><ref id="b26-med-2015-0046"><label>26</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Soulie</surname><given-names>M</given-names></name><name><surname>Cuvillier</surname><given-names>X</given-names></name><name><surname>Benaissa</surname><given-names>A</given-names></name><name><surname>Mouly</surname><given-names>P</given-names></name><name><surname>Larroque</surname><given-names>JM</given-names></name><name><surname>Bernstein</surname><given-names>J</given-names></name><etal/></person-group><article-title>The tension free transvaginal tape procedure in the treatment of female urinary stress incontinence: a French prospective multicentre study</article-title><source>Eur Urol</source><year>2001</year><volume>39</volume><fpage>709</fpage><lpage>714</lpage><pub-id pub-id-type="pmid">11464062</pub-id></element-citation></ref><ref id="b27-med-2015-0046"><label>27</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nilsson</surname><given-names>CG</given-names></name><name><surname>Falconer</surname><given-names>C</given-names></name><name><surname>Rezapour</surname><given-names>M</given-names></name></person-group><article-title>Seven year follow-up of the tension-free vaginal tape procedure for treatment of urinary incontinence</article-title><source>Obstet Gynecol</source><year>2004</year><volume>104</volume><fpage>1259</fpage><lpage>1262</lpage><pub-id pub-id-type="pmid">15572486</pub-id></element-citation></ref><ref id="b28-med-2015-0046"><label>28</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jomaa</surname><given-names>M</given-names></name></person-group><article-title>A seven-year follow-up of tension free vaginal tape (TVT) for surgical treatment of female stress urinary incontinence under local anaesthesia</article-title><source>Int Urogynecol J</source><year>2003</year><volume>14</volume><fpage>S69</fpage><comment>abstract</comment></element-citation></ref><ref id="b29-med-2015-0046"><label>29</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rafii</surname><given-names>A</given-names></name><name><surname>Paoletti</surname><given-names>X</given-names></name><name><surname>Haab</surname><given-names>F</given-names></name><name><surname>Levardon</surname><given-names>M</given-names></name><name><surname>Deval</surname><given-names>B</given-names></name></person-group><article-title>Tension-free vaginal tape and associated procedures: a case control study</article-title><source>Eur Urol</source><year>2004</year><volume>45</volume><fpage>356</fpage><lpage>361</lpage><pub-id pub-id-type="pmid">15036683</pub-id></element-citation></ref><ref id="b30-med-2015-0046"><label>30</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Munir</surname><given-names>N</given-names></name><name><surname>Bunce</surname><given-names>C</given-names></name><name><surname>Gelister</surname><given-names>J</given-names></name><name><surname>Briggs</surname><given-names>T</given-names></name></person-group><article-title>Outcome following TVT sling procedure: a comparison of outcome recorded by surgeons to that reported by their patients at a London district general hospital</article-title><source>Eur Urol</source><year>2005</year><volume>47</volume><fpage>635</fpage><lpage>640</lpage><pub-id pub-id-type="pmid">15826755</pub-id></element-citation></ref><ref id="b31-med-2015-0046"><label>31</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schraffordt Koops</surname><given-names>SE</given-names></name><name><surname>Bisseling</surname><given-names>TM</given-names></name><name><surname>Heintz</surname><given-names>APM</given-names></name><etal/></person-group><article-title>Prospective analysis of complications of tension-free vaginal tape from The Netherlands Tension-free Vaginal Tape study</article-title><source>Am J Obstet Gynecol</source><year>2005</year><volume>193</volume><fpage>45</fpage><lpage>52</lpage><pub-id pub-id-type="pmid">16021057</pub-id></element-citation></ref><ref id="b32-med-2015-0046"><label>32</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Abouassaly</surname><given-names>R</given-names></name><name><surname>Jordan</surname><given-names>R</given-names></name><name><surname>Steinberg</surname><given-names>R</given-names></name><etal/></person-group><article-title>Complications of tension-free vaginal tape surgery: a multi-institutional review</article-title><source>BJU Int</source><year>2004</year><volume>94</volume><fpage>110</fpage><lpage>113</lpage><pub-id pub-id-type="pmid">15217442</pub-id></element-citation></ref><ref id="b33-med-2015-0046"><label>33</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nilsson</surname><given-names>CG</given-names></name><name><surname>Kuuva</surname><given-names>N</given-names></name></person-group><article-title>The tension-free vaginal tape procedure is successful in the majority of women with indications for surgical treatment of urinary stress incontinence</article-title><source>BJOG</source><year>2001</year><volume>108</volume><fpage>414</fpage><lpage>419</lpage><pub-id pub-id-type="pmid">11305550</pub-id></element-citation></ref><ref id="b34-med-2015-0046"><label>34</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Niknejad</surname><given-names>K</given-names></name><name><surname>Plzak</surname><given-names>LS</given-names></name><name><surname>Staskin</surname><given-names>DR</given-names></name><etal/></person-group><article-title>Autologous and synthetic urethral slings for female incontinence</article-title><source>Urol Clin North Am</source><year>2002</year><volume>29</volume><fpage>597</fpage><lpage>611</lpage><pub-id pub-id-type="pmid">12476523</pub-id></element-citation></ref><ref id="b35-med-2015-0046"><label>35</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Delorme</surname><given-names>E</given-names></name></person-group><article-title>Transobturator urethral suspension: mini invasive procedure in the treatment of stress urinary incontinence in women</article-title><source>Prog Urol</source><year>2001</year><volume>11</volume><fpage>1306</fpage><lpage>1313</lpage><pub-id pub-id-type="pmid">11859672</pub-id></element-citation></ref><ref id="b36-med-2015-0046"><label>36</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>De Leval</surname><given-names>J</given-names></name></person-group><article-title>Novel surgical technique for the treatment of female stress urinary incontinence: transobturator vaginal tape inside-out</article-title><source>Eur Urol</source><year>2003</year><volume>44</volume><fpage>724</fpage><lpage>730</lpage><pub-id pub-id-type="pmid">14644127</pub-id></element-citation></ref><ref id="b37-med-2015-0046"><label>37</label><element-citation publication-type="webpage"><person-group person-group-type="author"><name><surname>Bariliene</surname><given-names>S</given-names></name><name><surname>Aniuliene</surname><given-names>R</given-names></name></person-group><article-title>New surgical treatment of female stress urinary incontinence</article-title><source>Medicina</source><issn>1010-660X.2007.43.N.8.671-675</issn><comment><ext-link ext-link-type="uri" xlink:href="http://medicina.lt">http://medicina.lt</ext-link></comment></element-citation></ref><ref id="b38-med-2015-0046"><label>38</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Aniuliene</surname><given-names>R</given-names></name><name><surname>Bariliene</surname><given-names>S</given-names></name></person-group><article-title>Analysis of new surgical treatment of female urinary incontinence in department of obstetrics and gynecology of Kaunas university hospital</article-title><source>Medicina</source><issn>1010-660X</issn><year>2006</year><volume>42</volume><issue>9</issue><fpage>725</fpage><lpage>731</lpage><comment><ext-link ext-link-type="uri" xlink:href="http://medicina.lt">http://medicina.lt</ext-link></comment><pub-id pub-id-type="pmid">17028470</pub-id></element-citation></ref><ref id="b39-med-2015-0046"><label>39</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fisher</surname><given-names>A</given-names></name><name><surname>Fink</surname><given-names>T</given-names></name><name><surname>Zachmann</surname><given-names>S</given-names></name><name><surname>Eickenbusch</surname><given-names>U</given-names></name></person-group><article-title>Comparison of retropubic and outside-in transobturator sling systems for the cure of female genuine stress urinary incontinence</article-title><source>Eur Urol</source><year>2005</year><volume>48</volume><fpage>799</fpage><lpage>804</lpage><pub-id pub-id-type="pmid">16140455</pub-id></element-citation></ref><ref id="b40-med-2015-0046"><label>40</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Andonian</surname><given-names>S</given-names></name><name><surname>Denis</surname><given-names>B</given-names></name><name><surname>Lemieux</surname><given-names>MC</given-names></name><etal/></person-group><article-title>Prospective clinical trial comparing Obtape and DUPS to TVT: one year safety and efficacy results</article-title><source>Eur Urol</source><year>2007</year><volume>52</volume><fpage>245</fpage><lpage>255</lpage><pub-id pub-id-type="pmid">17234331</pub-id></element-citation></ref><ref id="b41-med-2015-0046"><label>41</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Andonian</surname><given-names>S</given-names></name><name><surname>Chen</surname><given-names>ST</given-names></name><name><surname>Denis</surname><given-names>B</given-names></name><etal/></person-group><article-title>Randomized clinical trial comparing suprapubic arch sling (SPARC) and tension &#x02013;free vaginal tape (TVT): one year results</article-title><source>Eur Urol</source><year>2005</year><volume>47</volume><fpage>537</fpage><lpage>541</lpage><pub-id pub-id-type="pmid">15774255</pub-id></element-citation></ref><ref id="b42-med-2015-0046"><label>42</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lim</surname><given-names>YN</given-names></name><name><surname>Muller</surname><given-names>R</given-names></name><name><surname>Corstiaans</surname><given-names>A</given-names></name><etal/></person-group><article-title>Suburethral slingplasty evaluation study in North Queensland, Australia: the SUSPEND trial</article-title><source>Aust NZ J Obstet Gynaecol</source><year>2005</year><volume>45</volume><fpage>52</fpage><lpage>59</lpage></element-citation></ref><ref id="b43-med-2015-0046"><label>43</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lord</surname><given-names>HE</given-names></name><name><surname>Taylor</surname><given-names>JD</given-names></name><name><surname>Finn</surname><given-names>JC</given-names></name><etal/></person-group><article-title>A randomized controlled equivalence trial of short-term complications and efficacy of tension &#x02013; free vaginal tape and suprapubic urethral support sling for treating stress incontinence</article-title><source>BJU Int</source><year>2006</year><volume>98</volume><fpage>367</fpage><lpage>376</lpage><pub-id pub-id-type="pmid">16879679</pub-id></element-citation></ref><ref id="b44-med-2015-0046"><label>44</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tseng</surname><given-names>LH</given-names></name><name><surname>Wang</surname><given-names>AC</given-names></name><name><surname>Lin</surname><given-names>YH</given-names></name><etal/></person-group><article-title>Randomized comparison of the suprapubic arc sling procedure vs tension-free vaginal taping for stress incontinent women</article-title><source>Int Urogynecol J</source><year>2005</year><volume>16</volume><fpage>230</fpage><lpage>235</lpage><comment>[MEDLINE: 20354].[38NAU]</comment></element-citation></ref><ref id="b45-med-2015-0046"><label>45</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Taweel</surname><given-names>WA</given-names></name><name><surname>Rabah</surname><given-names>DM</given-names></name></person-group><article-title>Transobturator tape for female stress incontinence: follow-up after 24 months</article-title><source>CanUrol Assoc J</source><year>2010</year><volume>4</volume><fpage>33</fpage><lpage>36</lpage></element-citation></ref><ref id="b46-med-2015-0046"><label>46</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Araco</surname><given-names>F</given-names></name><name><surname>Gravente</surname><given-names>G</given-names></name><name><surname>Sorge</surname><given-names>R</given-names></name><etal/></person-group><article-title>TVT-O vs TVT: a randomized trial in patients with different degrees of urinary stress incontinence</article-title><source>Int Urogynecol J</source><year>2008</year><volume>19</volume><fpage>917</fpage><lpage>926</lpage></element-citation></ref><ref id="b47-med-2015-0046"><label>47</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Barry</surname><given-names>C</given-names></name><name><surname>Lim</surname><given-names>YN</given-names></name><name><surname>Muller</surname><given-names>R</given-names></name><etal/></person-group><article-title>A multicentre, randomized clinical control trial comparing the retropubic (RP) approach versus the transobturator approach (TO) for tension-free, suburethral sling treatment of urodynamic stress incontinence : the TORP study</article-title><source>Int Urogynecol J</source><year>2008</year><volume>19</volume><fpage>171</fpage><lpage>178</lpage></element-citation></ref><ref id="b48-med-2015-0046"><label>48</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Darai</surname><given-names>E</given-names></name><name><surname>Frobert</surname><given-names>JL</given-names></name><name><surname>Grisard-Anaf</surname><given-names>M</given-names></name><etal/></person-group><article-title>Functional results after the suburethral sling procedure for urinary stress incontinence : a prospective randomized multicentre study comparing the retropubic and transobturator routes</article-title><source>Eur Urol</source><year>2007</year><volume>51</volume><fpage>795</fpage><lpage>802</lpage><pub-id pub-id-type="pmid">17010507</pub-id></element-citation></ref><ref id="b49-med-2015-0046"><label>49</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Enzelsberger</surname><given-names>H</given-names></name><name><surname>Schalu</surname><given-names>J</given-names></name><name><surname>Heider</surname><given-names>R</given-names></name><etal/></person-group><article-title>TVT versus TOT: a prospective randomized study for the treatment of female stress urinary incontinence at a follow-up of 1 year</article-title><source>Geburtshilfe Frauenheilkd</source><year>2005</year><volume>65</volume><fpage>506</fpage><lpage>511</lpage></element-citation></ref><ref id="b50-med-2015-0046"><label>50</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Novara</surname><given-names>G</given-names></name><name><surname>Galfano</surname><given-names>A</given-names></name><name><surname>Boscolo-Berto</surname><given-names>R</given-names></name><etal/></person-group><article-title>Complication rate of tension-free midurethral slings in treatment of female stress urinary incontinence: a systematic review and meta-analysis of randomized trials comparing tension-free midurethral tapes to other surgical procedures and different devices</article-title><source>Eur Urol</source><year>2008</year><volume>53</volume><fpage>288</fpage><lpage>309</lpage><pub-id pub-id-type="pmid">18031923</pub-id></element-citation></ref><ref id="b51-med-2015-0046"><label>51</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fritel</surname><given-names>X</given-names></name><name><surname>Fauconnier</surname><given-names>A</given-names></name><name><surname>Bader</surname><given-names>G</given-names></name><name><surname>Cosson</surname><given-names>M</given-names></name><name><surname>Debodinance</surname><given-names>P</given-names></name><name><surname>Deffieux</surname><given-names>X</given-names></name></person-group><article-title>Diagnosis and treatment of adult female stress urinary incontinence: guidelines for clinical practice from French College of Gynecologists and Obstetricians. Review</article-title><source>Eur J of Obst/Gyn and reproductive biology</source><volume>151</volume><fpage>14</fpage><lpage>19</lpage><year>2010</year></element-citation></ref><ref id="b52-med-2015-0046"><label>52</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schussler</surname><given-names>B</given-names></name><name><surname>Alloussi</surname><given-names>S</given-names></name></person-group><article-title>Ingelman-Sundberg classification of stress incontinence</article-title><source>Gynacol Rundsch</source><year>1983</year><volume>23</volume><issue>3</issue><fpage>166</fpage><lpage>174</lpage></element-citation></ref></ref-list></back><floats-group><table-wrap id="t1-med-2015-0046" position="float"><label>Table 1</label><caption><p>Patients characteristics</p></caption><table frame="hsides" rules="groups"><thead><tr><th valign="middle" align="left" rowspan="1" colspan="1">Patients characteristics</th><th valign="middle" align="left" rowspan="1" colspan="1">TVT-Exact<break/>(n = 76)</th><th valign="middle" align="left" rowspan="1" colspan="1">SLING-IUFT<break/>(n = 78)</th><th valign="middle" align="left" rowspan="1" colspan="1">p</th></tr></thead><tbody><tr><td valign="top" align="left" rowspan="1" colspan="1">Age &#x000b1; SD</td><td valign="top" align="left" rowspan="1" colspan="1">50 &#x000b1; 8.9</td><td valign="top" align="left" rowspan="1" colspan="1">67 &#x000b1; 9.5</td><td valign="top" align="left" rowspan="1" colspan="1">p&#x0003c;0.05</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">POP Q system: Stage 1</td><td valign="top" align="left" rowspan="1" colspan="1">35</td><td valign="top" align="left" rowspan="1" colspan="1">21</td><td valign="top" align="left" rowspan="1" colspan="1">NS</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Stage 2</td><td valign="top" align="left" rowspan="1" colspan="1">41</td><td valign="top" align="left" rowspan="1" colspan="1">57</td><td valign="top" align="left" rowspan="1" colspan="1">NS</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Follow up period (months)</td><td valign="top" align="left" rowspan="1" colspan="1">12</td><td valign="top" align="left" rowspan="1" colspan="1">12</td><td valign="top" align="left" rowspan="1" colspan="1">NS</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">BMI, kg/m2</td><td valign="top" align="left" rowspan="1" colspan="1">28.5 &#x000b1; 3.5</td><td valign="top" align="left" rowspan="1" colspan="1">28.2 &#x000b1; 3.8</td><td valign="top" align="left" rowspan="1" colspan="1">NS</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Parity</td><td valign="top" align="left" rowspan="1" colspan="1">2.1 &#x000b1; 1.1</td><td valign="top" align="left" rowspan="1" colspan="1">2.5 &#x000b1; 1.2</td><td valign="top" align="left" rowspan="1" colspan="1">NS</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Birth weight &#x0003e; 3500 g</td><td valign="top" align="left" rowspan="1" colspan="1">49 &#x000b1; 1.2</td><td valign="top" align="left" rowspan="1" colspan="1">51 &#x000b1; 1.3</td><td valign="top" align="left" rowspan="1" colspan="1">NS</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Menopause (1 &#x02013; 30 years)</td><td valign="top" align="left" rowspan="1" colspan="1">38</td><td valign="top" align="left" rowspan="1" colspan="1">55</td><td valign="top" align="left" rowspan="1" colspan="1">p&#x0003c;0.05</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Obesity (BMI &#x0003e; 30)</td><td valign="top" align="left" rowspan="1" colspan="1">10</td><td valign="top" align="left" rowspan="1" colspan="1">11</td><td valign="top" align="left" rowspan="1" colspan="1">NS</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Irritated bladder symptoms</td><td valign="top" align="left" rowspan="1" colspan="1">6</td><td valign="top" align="left" rowspan="1" colspan="1">5</td><td valign="top" align="left" rowspan="1" colspan="1">NS</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Urinary incontinence period</td><td valign="top" align="left" rowspan="1" colspan="1">8.5 &#x000b1; 2.7</td><td valign="top" align="left" rowspan="1" colspan="1">7.5 &#x000b1; 2.9</td><td valign="top" align="left" rowspan="1" colspan="1">NS</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Hysterectomy in the past</td><td valign="top" align="left" rowspan="1" colspan="1">11</td><td valign="top" align="left" rowspan="1" colspan="1">15</td><td valign="top" align="left" rowspan="1" colspan="1">NS</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Operated incontinence in the past</td><td valign="top" align="left" rowspan="1" colspan="1">8</td><td valign="top" align="left" rowspan="1" colspan="1">7</td><td valign="top" align="left" rowspan="1" colspan="1">NS</td></tr></tbody></table><table-wrap-foot><fn id="tfn1-med-2015-0046"><p>NS: non significant</p></fn></table-wrap-foot></table-wrap><table-wrap id="t2-med-2015-0046" position="float"><label>Table 2</label><caption><p>Register data of TVT-Exact and SLING-IUFT procedure</p></caption><table frame="hsides" rules="groups"><thead><tr><th valign="bottom" align="left" rowspan="1" colspan="1">Register parameters</th><th valign="bottom" align="left" rowspan="1" colspan="1">TVT-Exact (n = 76)</th><th valign="bottom" align="left" rowspan="1" colspan="1">SLING-IUFT (n = 78)</th><th valign="bottom" align="left" rowspan="1" colspan="1">p</th></tr></thead><tbody><tr><td valign="top" align="left" rowspan="1" colspan="1">&#x02003;Effectiveness of procedure (cure rate)</td><td valign="top" align="left" rowspan="1" colspan="1">94.5%</td><td valign="top" align="left" rowspan="1" colspan="1">61.2%</td><td valign="top" align="left" rowspan="1" colspan="1">p&#x0003c;0.05</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">&#x02003;Duration of procedure</td><td valign="top" align="left" rowspan="1" colspan="1">21 &#x000b1; 9.1</td><td valign="top" align="left" rowspan="1" colspan="1">19 &#x000b1; 5.7</td><td valign="top" align="left" rowspan="1" colspan="1">NS</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">&#x02003;Hospital stay (days)</td><td valign="top" align="left" rowspan="1" colspan="1">3.5 &#x000b1; 1.5</td><td valign="top" align="left" rowspan="1" colspan="1">1.5 &#x000b1; 0.5</td><td valign="top" align="left" rowspan="1" colspan="1">p&#x0003c;0.05</td></tr><tr><td colspan="4" valign="top" align="left" rowspan="1">Anesthesia:</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">&#x02003;Lumbar</td><td valign="top" align="left" rowspan="1" colspan="1">15 (19.7%)</td><td valign="top" align="left" rowspan="1" colspan="1">11 (14.1%)</td><td valign="top" align="left" rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">&#x02003;Intravenous</td><td valign="top" align="left" rowspan="1" colspan="1">61 (80.2%)</td><td valign="top" align="left" rowspan="1" colspan="1">67 (85.8%)</td><td valign="top" align="left" rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">&#x02003;Concomitant surgery</td><td valign="top" align="left" rowspan="1" colspan="1">25</td><td valign="top" align="left" rowspan="1" colspan="1">26</td><td valign="top" align="left" rowspan="1" colspan="1">NS</td></tr><tr><td colspan="4" valign="top" align="left" rowspan="1">Bladder drainage:</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">- Interrupted catheterization</td><td valign="top" align="left" rowspan="1" colspan="1">12 (15.7%)</td><td valign="top" align="left" rowspan="1" colspan="1">1 (1.3%)</td><td valign="top" align="left" rowspan="1" colspan="1">p&#x0003c;0.05</td></tr></tbody></table><table-wrap-foot><fn id="tfn2-med-2015-0046"><p>NS: non significant</p></fn></table-wrap-foot></table-wrap><table-wrap id="t3-med-2015-0046" position="float"><label>Table 3</label><caption><p>TVT-Exact and SLING-IUFT procedures follow-up results.</p></caption><table frame="hsides" rules="groups"><thead><tr><th valign="bottom" align="left" rowspan="1" colspan="1">Results (after 1 year)</th><th valign="bottom" align="left" rowspan="1" colspan="1">TVT-Exact<break/>N = 76</th><th valign="bottom" align="left" rowspan="1" colspan="1">SLING-IUFT<break/>N = 78</th></tr></thead><tbody><tr><td valign="top" align="left" rowspan="1" colspan="1">Excellent</td><td valign="top" align="left" rowspan="1" colspan="1">60 (78.9%)</td><td valign="top" align="left" rowspan="1" colspan="1">35 (44.8%)</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Good</td><td valign="top" align="left" rowspan="1" colspan="1">11 (14.5%)</td><td valign="top" align="left" rowspan="1" colspan="1">10 (12.9%)</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Medium</td><td valign="top" align="left" rowspan="1" colspan="1">1 (1.3%)</td><td valign="top" align="left" rowspan="1" colspan="1">2 (2.6%)</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Bad</td><td valign="top" align="left" rowspan="1" colspan="1">4 (5.3%)</td><td valign="top" align="left" rowspan="1" colspan="1">31 (39.7%)</td></tr></tbody></table><table-wrap-foot><fn id="tfn3-med-2015-0046"><p>p&#x0003c;0.0001</p></fn></table-wrap-foot></table-wrap><table-wrap id="t4-med-2015-0046" position="float"><label>Table 4</label><caption><p>Postoperative complications</p></caption><table frame="hsides" rules="groups"><thead><tr><th valign="middle" align="left" rowspan="1" colspan="1">Complications</th><th valign="middle" align="left" rowspan="1" colspan="1">TVTexact (n = 76)</th><th valign="middle" align="left" rowspan="1" colspan="1">SLING-IUFT (n = 78)</th><th valign="middle" align="left" rowspan="1" colspan="1">p</th></tr></thead><tbody><tr><td valign="top" align="left" rowspan="1" colspan="1">None</td><td valign="top" align="left" rowspan="1" colspan="1">49 (64.6%)</td><td valign="top" align="left" rowspan="1" colspan="1">66 (84.6%)</td><td valign="top" align="left" rowspan="1" colspan="1">p&#x0003c;0.05</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Suprapubic hematoma</td><td valign="top" align="left" rowspan="1" colspan="1">3 (3.9%)</td><td valign="top" align="left" rowspan="1" colspan="1">0</td><td valign="top" align="left" rowspan="1" colspan="1">p&#x0003c;0.05</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Bladder perforation</td><td valign="top" align="left" rowspan="1" colspan="1">1 (1.3%)</td><td valign="top" align="left" rowspan="1" colspan="1">0</td><td valign="top" align="left" rowspan="1" colspan="1">NS</td></tr><tr><td colspan="4" valign="top" align="left" rowspan="1">
<hr/></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Postoperative urinary retention</td><td valign="top" align="left" rowspan="1" colspan="1">15 (19.7%)</td><td valign="top" align="left" rowspan="1" colspan="1">1 (1.3%)</td><td valign="top" align="left" rowspan="1" colspan="1">p&#x0003c;0.05</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Symptoms of irritated bladder</td><td valign="top" align="left" rowspan="1" colspan="1">7 (9.2%)</td><td valign="top" align="left" rowspan="1" colspan="1">5 (6.4%)</td><td valign="top" align="left" rowspan="1" colspan="1">NS</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Postoperative groin pain</td><td valign="top" align="left" rowspan="1" colspan="1">1(1.3%)</td><td valign="top" align="left" rowspan="1" colspan="1">5(6.4 %)</td><td valign="top" align="left" rowspan="1" colspan="1">p&#x0003c;0.05</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Vaginal erosion</td><td valign="top" align="left" rowspan="1" colspan="1">0</td><td valign="top" align="left" rowspan="1" colspan="1">1(1.3%)</td><td valign="top" align="left" rowspan="1" colspan="1">NS</td></tr></tbody></table><table-wrap-foot><fn id="tfn4-med-2015-0046"><p>NS- non significant</p></fn></table-wrap-foot></table-wrap></floats-group></article>